Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Here's a look at some of the top funding stories for medical device companies this week: DICOM Grid raises $6M for cloud-based medical imaging systems; Welch Allyn leads $7M round for Cardiac Insight; Biolase launches $12M private placement amid internal turmoil, shares soar; Trice Medical reels in $12M, ex-Embrella founder O'Donnell
New stented aortic bioprosthesis delivers outstanding implantability and performance.
Milan, Italy – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today it has been granted CE mark certification for its innovative stented aortic bioprosthesis Crown PRT, now commercially available in Europe.